Trials / Completed
CompletedNCT00000227
Alternate-Day Buprenorphine Administration. Phase VIII - 9
Alternate-Day Buprenorphine Administration. Phase VIII
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- University of Vermont · Academic / Other
- Sex
- All
- Age
- 25 Years – 48 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate open buprenorphine dosing with dose choice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buprenorphine |
Timeline
- Start date
- 1994-08-01
- First posted
- 1999-09-21
- Last updated
- 2016-05-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000227. Inclusion in this directory is not an endorsement.